首页 | 本学科首页   官方微博 | 高级检索  
     

吉西他滨与奥沙利铂联合化疗治疗晚期膀胱癌的疗效和不良反应
引用本文:张治业,高晓会,郭双双,姚俊,郭艳珍,张殿宝. 吉西他滨与奥沙利铂联合化疗治疗晚期膀胱癌的疗效和不良反应[J]. 现代预防医学, 2011, 38(16): 3385-3386,3389
作者姓名:张治业  高晓会  郭双双  姚俊  郭艳珍  张殿宝
作者单位:河南科技大学第一附属医院肿瘤内科,洛阳,471003
摘    要:[目的]探讨吉西他滨联合奥沙利铂方案治疗晚期膀胱癌的疗效及不良反应。[方法]56例Ⅳ期膀胱癌接受吉西他滨联合奥沙利铂方案化疗:吉西他滨1000mg/m2,d1和d8,奥沙利铂135mg/m2,d1;21d为1个周期,每2疗程评价疗效。[结果]本组65例晚期膀胱癌患者完全缓解(CR)3例(5.36%),部分缓解(PR)27例(48.21%),总有效率(CR+PR)43.57%。在疼痛缓解、全身情况明显改善,生存质量和KPS评分提高等方面均取得了较好疗效。主要不良反应为骨髓抑制、外周神经毒性、消化道反应等。无治疗相关死亡者。[结论]吉西他滨与奥沙利铂联合化疗是治疗晚期膀胱癌的有效方法,并且毒副反应相对较轻。

关 键 词:吉西他滨  奥沙利铂  膀胱癌

CURATIVE EFFECT AND ADVERSE REACTIONS OF GEMCITABINE COMBINED WITH OXALIPLATIN IN TREATMENT OF LATE BLADDER CANCER
ZHANG Zhi-ye,GAO Xiao-hui,GUO Shuang-shuang,et al.. CURATIVE EFFECT AND ADVERSE REACTIONS OF GEMCITABINE COMBINED WITH OXALIPLATIN IN TREATMENT OF LATE BLADDER CANCER[J]. Modern Preventive Medicine, 2011, 38(16): 3385-3386,3389
Authors:ZHANG Zhi-ye  GAO Xiao-hui  GUO Shuang-shuang  et al.
Affiliation:ZHANG Zhi-ye,GAO Xiao-hui,GUO Shuang-shuang,et al.(Department of Oncology,the First Affiliated Hospital of Henan University of Technology,Luoyang 471003,China)
Abstract:[Objective]To evaluate the efficiency and adverse reactions of gemcitabine combined with oxaliplatin in treatment of later bladder cancer.[Methods]56 patients with metastatic bladder cancer were treated with gemcitabine 1 000 mg/m2 on d1,d8 and L-OHP 135mg/m2 on d1,and every 21 days as one cycle. After two consecutive treatment courses,the evaluation of the short term efficacy and adverse effects was carried out.[Results]65 patients were evaluable for response. Major objective responses were observed in 30 ...
Keywords:Gemcitabine  Oxaliplatin  Bladder cancer  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号